.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Redcliffe Labs recently announced the Redcliffe Labs COO appointment by elevating Gaurav Jain to this pivotal leadership role. Jain previously served as the Senior Vice President and Head of Growth within the organization. Consequently, this promotion reflects the company's commitment to internal talent development while scaling its operations. Jain brings over twenty years of experience in pharmaceuticals and diagnostics to his new position. This extensive expertise will support the company's technology-driven diagnostic platform.
In his new capacity, Jain will lead several growth initiatives across India. He will also oversee daily operations and maintain clinical quality standards. Furthermore, Redcliffe Labs aims to scale its preventive diagnostics services significantly. Jain joined the organization in November 2021. Since then, he has spearheaded the development of an extensive home-collection phlebotomy network. This network has strengthened last-mile connectivity and service reach for patients across the country.
The diagnostic chain has already touched over one crore lives in India. Additionally, Aditya Kandoi, the Founder and CEO, praised Jain’s ability to deliver impact at scale. Jain stated that the professional journey has been transformational. Moreover, he plans to move India from illness care toward proactive healthcare. This transition is essential for the evolving healthcare landscape. The company continues to focus on nurturing leaders from within to drive innovation.
Q1: Who is the new COO of Redcliffe Labs?
Gaurav Jain is the newly appointed Chief Operating Officer, having previously served as the Senior Vice President and Head of Growth since 2021.
Q2: What are the primary responsibilities of the new COO?
Jain will oversee operations, clinical quality, and growth initiatives to scale the company's technology-driven preventive diagnostics platform.
Q3: How many patients has Redcliffe Labs served to date?
Redcliffe Labs has impacted more than one crore (ten million) lives across India through its diagnostic services.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Redcliffe Labs elevates Gaurav Jain to Chief Operating Officer to drive strategic growth and enhance preventive diagnostic services across the Indian market...
5 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
